South Korea, August 2016 – Novartis Korea execs indicted over rebates

Six former and current Novartis Korea employees, including the former CEO, were indicted in August 2016, for providing US$2.34 million to doctors in return for using the company’s products.

The inducements were provided by funding academic events organised by complicit medical publications, with money given to doctors for attending the events and writing articles for the publications.

Novartis Korea rejected the allegations that the executives knew of any illegal activities, saying that while internal investigations had uncovered some unfair trade practices, the activities were not conducted with the knowledge of executives.